EX-10.13 2 d553644dex1013.htm EX-10.13 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under SUPPLY, SERVICE, AND SUPPORT AGREEMENTSupply, Service, and Support Agreement • May 5th, 2020 • New York
This Supply, Service, and Support Agreement (the “Agreement”) is effective as of the date of last signature found below (the “Effective Date”) between Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 (“Illumina”) and Foundation Medicine Inc. , having a place of business at One Kendall Square, Suite B3501, Cambridge, MA, 02139 (“Customer”). Customer and Illumina may be referred to herein as “Party” or “Parties.”
EX-10.1 2 fmi-ex101_237.htm EX-10.1 AMENDMENT #2 TO SUPPLY, SERVICE, AND SUPPORT AGREEMENTSupply, Service, and Support Agreement • May 5th, 2020
Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 and Foundation Medicine Inc., having a place of business at 150 Second Street, Cambridge, MA 02141, entered into that certain Supply, Service, and Support Agreement dated July 25, 2013, as amended by Amendment #1 dated October 1, 2016 (collectively, “Agreement”). The Parties desire to amend the Agreement by entering into this Amendment #2 (“Amendment #2”) as of the date of last signature below (“Amendment #2 Effective Date”).
AMENDMENT #1 TO SUPPLY, SERVICE, AND SUPPORT AGREEMENTSupply, Service, and Support Agreement • March 3rd, 2017 • Foundation Medicine, Inc. • Services-medical laboratories
Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 (“Illumina”) and Foundation Medicine Inc., having a place of business at 150 Second Street, Cambridge, MA 02141 (“Customer”), entered into that certain Supply, Service, and Support Agreement dated July 25, 2013 (“Agreement”). Customer and Illumina may be referred to herein as “Party” or “Parties.” The Parties desire to amend the Agreement by entering into this Amendment #1 (“Amendment #1”) as of the date of last signature below (“Amendment #1 Effective Date”).
AMENDED AND RESTATED SUPPLY, SERVICE, AND SUPPORT AGREEMENTSupply, Service, and Support Agreement • August 9th, 2018 • Foundation Medicine, Inc. • Services-medical laboratories • New York
This Amended and Restated Supply, Service, and Support Agreement (this “Agreement”) is effective as of the date of last signature found below (the “Restatement Date”) between Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 (“Illumina”) and Foundation Medicine, Inc. (“FMI”) having a place of business at 150 Second Street, Cambridge, MA, 02141, on behalf of itself and its Ordering Affiliates (collectively, “Customer”), and amends and restates that certain Supply, Service, and Support Agreement dated July 25, 2013 (“Effective Date”) between Foundation Medicine, Inc. and Illumina, as amended (“Prior Agreement”). Upon execution, the terms of this Agreement shall supersede and control over the terms of the Prior Agreement. Customer and Illumina may be referred to herein as “Party” or “Parties.”
AMENDMENT #1 TO SUPPLY, SERVICE, AND SUPPORT AGREEMENTSupply, Service, and Support Agreement • March 30th, 2017 • Foundation Medicine, Inc. • Services-medical laboratories
Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 (“Illumina”) and Foundation Medicine Inc., having a place of business at 150 Second Street, Cambridge, MA 02141 (“Customer”), entered into that certain Supply, Service, and Support Agreement dated July 25, 2013 (“Agreement”). Customer and Illumina may be referred to herein as “Party” or “Parties.” The Parties desire to amend the Agreement by entering into this Amendment #1 (“Amendment #1”) as of the date of last signature below (“Amendment #1 Effective Date”).
